{Reference Type}: Journal Article
{Title}: The ethical case for placebo control in HIV-cure-related studies with ART interruption.
{Author}: Magalhaes M;Kuritzkes DR;Eyal N;Magalhaes M;Kuritzkes DR;Eyal N;
{Journal}: J Virus Erad
{Volume}: 8
{Issue}: 3
{Year}: Sep 2022
{Factor}: 5.148
{DOI}: 10.1016/j.jve.2022.100084
{Abstract}: Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.